Search Tag: Cardiac amyloidosis

2025 10 Jul

A new study shows that an artificial intelligence (AI) model developed by Mayo Clinic and Ultromics, Ltd., an AI echocardiography company in Oxford, England, is highly accurate at screening for cardiac amyloidosis, a rare, progressive form of heart failure. It is the first and only AI tool designed specifically for this purpose.   Researchers...Read more